 Catherine Lozupone
Concepts (388)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteria | 39 | 2022 | 757 | 5.130 |
Why?
| | Microbiota | 21 | 2022 | 656 | 4.820 |
Why?
| | Gastrointestinal Microbiome | 21 | 2024 | 548 | 4.100 |
Why?
| | Phylogeny | 28 | 2020 | 816 | 2.810 |
Why?
| | Software | 10 | 2022 | 613 | 1.910 |
Why?
| | RNA, Ribosomal, 16S | 29 | 2019 | 514 | 1.810 |
Why?
| | Metagenome | 13 | 2015 | 121 | 1.780 |
Why?
| | Feces | 16 | 2021 | 396 | 1.570 |
Why?
| | Gastrointestinal Tract | 13 | 2019 | 175 | 1.570 |
Why?
| | Biodiversity | 12 | 2018 | 378 | 1.450 |
Why?
| | HIV Infections | 16 | 2022 | 2459 | 1.400 |
Why?
| | Intestines | 8 | 2018 | 332 | 1.360 |
Why?
| | Interleukin-10 | 3 | 2022 | 306 | 1.350 |
Why?
| | Symbiosis | 6 | 2020 | 63 | 1.340 |
Why?
| | Dysbiosis | 5 | 2021 | 147 | 1.320 |
Why?
| | Metabolome | 2 | 2019 | 296 | 1.060 |
Why?
| | Computational Biology | 7 | 2019 | 588 | 1.050 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 137 | 0.930 |
Why?
| | Anti-Retroviral Agents | 4 | 2021 | 208 | 0.880 |
Why?
| | Leukocytes, Mononuclear | 3 | 2022 | 509 | 0.860 |
Why?
| | Bacterial Toxins | 1 | 2022 | 106 | 0.810 |
Why?
| | Polysaccharides, Bacterial | 3 | 2022 | 69 | 0.780 |
Why?
| | Immune System | 2 | 2019 | 181 | 0.770 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 176 | 0.760 |
Why?
| | Blood Group Antigens | 1 | 2020 | 16 | 0.760 |
Why?
| | Ecosystem | 10 | 2017 | 555 | 0.730 |
Why?
| | Disease | 2 | 2019 | 98 | 0.730 |
Why?
| | Health | 2 | 2017 | 81 | 0.700 |
Why?
| | Audiovisual Aids | 1 | 2019 | 17 | 0.680 |
Why?
| | Prevotella | 1 | 2018 | 12 | 0.680 |
Why?
| | DNA, Bacterial | 7 | 2019 | 314 | 0.670 |
Why?
| | Bacterial Infections | 2 | 2020 | 227 | 0.670 |
Why?
| | Dolphins | 1 | 2017 | 2 | 0.640 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 465 | 0.610 |
Why?
| | Genetic Techniques | 2 | 2008 | 60 | 0.580 |
Why?
| | Metagenomics | 5 | 2013 | 134 | 0.580 |
Why?
| | Soil Microbiology | 6 | 2011 | 183 | 0.580 |
Why?
| | Genetic Variation | 9 | 2011 | 926 | 0.580 |
Why?
| | Sequence Analysis, DNA | 11 | 2017 | 755 | 0.530 |
Why?
| | Humans | 68 | 2024 | 118974 | 0.520 |
Why?
| | Bacterial Physiological Phenomena | 5 | 2020 | 57 | 0.510 |
Why?
| | Immunotherapy | 1 | 2019 | 493 | 0.510 |
Why?
| | Immune Tolerance | 1 | 2016 | 334 | 0.490 |
Why?
| | Archaea | 3 | 2011 | 70 | 0.480 |
Why?
| | Tropheryma | 1 | 2013 | 4 | 0.470 |
Why?
| | Whipple Disease | 1 | 2013 | 5 | 0.470 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 359 | 0.470 |
Why?
| | Biota | 1 | 2013 | 37 | 0.460 |
Why?
| | Obesity | 5 | 2021 | 2746 | 0.460 |
Why?
| | Ecology | 3 | 2011 | 104 | 0.450 |
Why?
| | Animals | 33 | 2022 | 33381 | 0.450 |
Why?
| | Homosexuality, Male | 4 | 2022 | 166 | 0.420 |
Why?
| | Microbiological Techniques | 2 | 2010 | 31 | 0.420 |
Why?
| | Cluster Analysis | 8 | 2010 | 481 | 0.420 |
Why?
| | Liver Transplantation | 1 | 2019 | 847 | 0.400 |
Why?
| | Genes, Bacterial | 4 | 2011 | 162 | 0.380 |
Why?
| | Molecular Sequence Data | 15 | 2013 | 2871 | 0.370 |
Why?
| | Host-Pathogen Interactions | 4 | 2019 | 300 | 0.340 |
Why?
| | Genes, Archaeal | 1 | 2008 | 7 | 0.340 |
Why?
| | Glycosyltransferases | 1 | 2008 | 13 | 0.340 |
Why?
| | Glycoside Hydrolases | 1 | 2008 | 30 | 0.330 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 336 | 0.330 |
Why?
| | Isoleucine | 2 | 2005 | 12 | 0.310 |
Why?
| | Hot Springs | 1 | 2007 | 7 | 0.300 |
Why?
| | Digestive System | 1 | 2007 | 30 | 0.300 |
Why?
| | Geologic Sediments | 1 | 2007 | 37 | 0.290 |
Why?
| | Evolution, Molecular | 5 | 2012 | 454 | 0.280 |
Why?
| | Genome, Bacterial | 5 | 2021 | 109 | 0.280 |
Why?
| | RNA | 3 | 2012 | 833 | 0.260 |
Why?
| | Ciliophora | 2 | 2003 | 14 | 0.260 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2019 | 280 | 0.260 |
Why?
| | Cohort Studies | 9 | 2021 | 5116 | 0.250 |
Why?
| | Neoplasms | 1 | 2019 | 2179 | 0.250 |
Why?
| | Body Mass Index | 4 | 2019 | 2092 | 0.240 |
Why?
| | Receptors, CCR5 | 2 | 2021 | 54 | 0.240 |
Why?
| | Homeostasis | 2 | 2018 | 594 | 0.240 |
Why?
| | Lung | 2 | 2013 | 3664 | 0.240 |
Why?
| | HIV | 2 | 2019 | 210 | 0.230 |
Why?
| | Anti-Bacterial Agents | 3 | 2022 | 1510 | 0.220 |
Why?
| | Internet | 2 | 2011 | 633 | 0.220 |
Why?
| | Bifidobacterium | 3 | 2017 | 22 | 0.220 |
Why?
| | Germ-Free Life | 3 | 2019 | 30 | 0.220 |
Why?
| | Mice | 12 | 2022 | 15520 | 0.220 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2018 | 453 | 0.220 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 11 | 0.220 |
Why?
| | Female | 25 | 2021 | 61565 | 0.220 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 531 | 0.210 |
Why?
| | Bacteroides | 3 | 2019 | 18 | 0.210 |
Why?
| | DNA, Ribosomal | 3 | 2013 | 79 | 0.210 |
Why?
| | Infant | 8 | 2021 | 8293 | 0.210 |
Why?
| | Environment | 3 | 2012 | 346 | 0.200 |
Why?
| | Peptide Termination Factors | 1 | 2001 | 5 | 0.200 |
Why?
| | Biological Evolution | 4 | 2009 | 443 | 0.200 |
Why?
| | Base Sequence | 9 | 2017 | 2159 | 0.200 |
Why?
| | Genetic Code | 1 | 2001 | 20 | 0.200 |
Why?
| | Male | 21 | 2022 | 57801 | 0.200 |
Why?
| | Firmicutes | 1 | 2021 | 20 | 0.200 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2020 | 260 | 0.190 |
Why?
| | Sexual Behavior | 3 | 2020 | 437 | 0.190 |
Why?
| | RNA, Bacterial | 4 | 2010 | 175 | 0.190 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2020 | 11 | 0.190 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.180 |
Why?
| | Benzopyrans | 1 | 2019 | 25 | 0.180 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 93 | 0.180 |
Why?
| | Western World | 1 | 2019 | 6 | 0.180 |
Why?
| | Dietary Fats | 1 | 2022 | 322 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2021 | 984 | 0.180 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2020 | 113 | 0.170 |
Why?
| | Liver Regeneration | 1 | 2019 | 34 | 0.170 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2513 | 0.170 |
Why?
| | Thiophenes | 1 | 2019 | 106 | 0.170 |
Why?
| | Behavior Therapy | 1 | 2021 | 237 | 0.170 |
Why?
| | Hypersensitivity | 1 | 2022 | 268 | 0.170 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2019 | 197 | 0.160 |
Why?
| | Datasets as Topic | 1 | 2019 | 103 | 0.160 |
Why?
| | Sequence Analysis | 2 | 2009 | 36 | 0.160 |
Why?
| | Metabolomics | 2 | 2021 | 550 | 0.160 |
Why?
| | Genes, rRNA | 4 | 2017 | 39 | 0.160 |
Why?
| | Asthma | 3 | 2022 | 2158 | 0.160 |
Why?
| | Streptococcus | 1 | 2017 | 25 | 0.160 |
Why?
| | Mouth | 1 | 2017 | 74 | 0.150 |
Why?
| | Transplantation, Homologous | 1 | 2019 | 415 | 0.150 |
Why?
| | Weight Gain | 2 | 2018 | 493 | 0.150 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 187 | 0.150 |
Why?
| | Microbial Consortia | 1 | 2017 | 18 | 0.150 |
Why?
| | Bacterial Load | 1 | 2017 | 61 | 0.150 |
Why?
| | Gene Transfer, Horizontal | 4 | 2010 | 26 | 0.150 |
Why?
| | Environmental Microbiology | 2 | 2007 | 41 | 0.150 |
Why?
| | Adult | 14 | 2021 | 31512 | 0.150 |
Why?
| | Algorithms | 2 | 2022 | 1541 | 0.140 |
Why?
| | Th17 Cells | 1 | 2016 | 57 | 0.140 |
Why?
| | Weight Loss | 1 | 2021 | 655 | 0.140 |
Why?
| | Life Style | 1 | 2018 | 430 | 0.140 |
Why?
| | Leukemia | 1 | 2018 | 208 | 0.140 |
Why?
| | Microbial Interactions | 1 | 2016 | 14 | 0.140 |
Why?
| | Pregnancy | 4 | 2017 | 5691 | 0.140 |
Why?
| | Cholestasis | 1 | 2019 | 228 | 0.140 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 670 | 0.140 |
Why?
| | Geography | 4 | 2012 | 190 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 187 | 0.130 |
Why?
| | Diet | 3 | 2018 | 1153 | 0.130 |
Why?
| | Microbiology | 1 | 2015 | 19 | 0.130 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 216 | 0.130 |
Why?
| | Pediatric Obesity | 2 | 2019 | 524 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2019 | 527 | 0.130 |
Why?
| | Benchmarking | 1 | 2016 | 172 | 0.120 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 356 | 0.120 |
Why?
| | Probability | 1 | 2015 | 305 | 0.120 |
Why?
| | Genomics | 2 | 2011 | 706 | 0.120 |
Why?
| | Infant, Newborn | 3 | 2020 | 5255 | 0.120 |
Why?
| | Colitis | 1 | 2016 | 219 | 0.120 |
Why?
| | Premature Birth | 1 | 2017 | 284 | 0.120 |
Why?
| | Sequence Alignment | 2 | 2012 | 336 | 0.120 |
Why?
| | Anti-HIV Agents | 2 | 2017 | 664 | 0.120 |
Why?
| | Environmental Exposure | 1 | 2017 | 405 | 0.110 |
Why?
| | Disease Models, Animal | 4 | 2017 | 3730 | 0.110 |
Why?
| | Pets | 1 | 2013 | 21 | 0.110 |
Why?
| | Glucose | 1 | 2018 | 953 | 0.110 |
Why?
| | Insulin Resistance | 2 | 2018 | 1180 | 0.110 |
Why?
| | Autism Spectrum Disorder | 1 | 2017 | 323 | 0.110 |
Why?
| | Tongue | 1 | 2013 | 73 | 0.110 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 126 | 0.110 |
Why?
| | Clostridium | 1 | 2012 | 15 | 0.110 |
Why?
| | Colon | 2 | 2020 | 238 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 36 | 0.110 |
Why?
| | Inflammation | 3 | 2022 | 2566 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1284 | 0.110 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 20 | 0.110 |
Why?
| | Middle Aged | 9 | 2021 | 27617 | 0.110 |
Why?
| | Cultured Milk Products | 1 | 2011 | 1 | 0.110 |
Why?
| | Housing | 1 | 2013 | 123 | 0.100 |
Why?
| | Mucin-5B | 1 | 2013 | 175 | 0.100 |
Why?
| | Fishes | 1 | 2012 | 85 | 0.100 |
Why?
| | Macaca mulatta | 2 | 2012 | 153 | 0.100 |
Why?
| | Antigens, CD | 2 | 2020 | 460 | 0.100 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 254 | 0.100 |
Why?
| | Child, Preschool | 7 | 2021 | 9491 | 0.100 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2012 | 98 | 0.100 |
Why?
| | Methanobrevibacter | 1 | 2011 | 1 | 0.100 |
Why?
| | Adolescent | 9 | 2021 | 18480 | 0.100 |
Why?
| | Genome, Archaeal | 1 | 2011 | 13 | 0.100 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2012 | 98 | 0.100 |
Why?
| | Adhesins, Bacterial | 1 | 2011 | 36 | 0.100 |
Why?
| | Risk Factors | 3 | 2020 | 9000 | 0.100 |
Why?
| | Cameroon | 2 | 2021 | 10 | 0.100 |
Why?
| | Phenotype | 1 | 2019 | 3003 | 0.100 |
Why?
| | Young Adult | 7 | 2021 | 10793 | 0.100 |
Why?
| | HIV-1 | 2 | 2018 | 776 | 0.100 |
Why?
| | RNA, Ribosomal | 2 | 2010 | 158 | 0.100 |
Why?
| | Child | 9 | 2022 | 19129 | 0.100 |
Why?
| | Residence Characteristics | 1 | 2013 | 299 | 0.100 |
Why?
| | Behavioral Symptoms | 1 | 2011 | 44 | 0.090 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 17 | 0.090 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2012 | 224 | 0.090 |
Why?
| | Crohn Disease | 1 | 2013 | 197 | 0.090 |
Why?
| | Comorbidity | 3 | 2022 | 1527 | 0.090 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 4708 | 0.090 |
Why?
| | Liver | 1 | 2018 | 1816 | 0.090 |
Why?
| | Twins | 1 | 2011 | 247 | 0.090 |
Why?
| | Family | 1 | 2013 | 585 | 0.090 |
Why?
| | Virus Replication | 2 | 2012 | 405 | 0.090 |
Why?
| | Fungi | 1 | 2010 | 123 | 0.090 |
Why?
| | Genome | 2 | 2010 | 277 | 0.080 |
Why?
| | Viral Load | 3 | 2018 | 419 | 0.080 |
Why?
| | CD4 Lymphocyte Count | 2 | 2021 | 267 | 0.080 |
Why?
| | Carbohydrates | 1 | 2008 | 59 | 0.080 |
Why?
| | Skin | 1 | 2013 | 657 | 0.080 |
Why?
| | Norway | 2 | 2018 | 35 | 0.080 |
Why?
| | Soil | 1 | 2010 | 181 | 0.080 |
Why?
| | Lentivirus Infections | 1 | 2008 | 7 | 0.080 |
Why?
| | Vertebrates | 1 | 2008 | 59 | 0.080 |
Why?
| | Monkey Diseases | 1 | 2008 | 21 | 0.080 |
Why?
| | Postoperative Complications | 1 | 2019 | 2235 | 0.080 |
Why?
| | Multigene Family | 1 | 2008 | 200 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 1974 | 0.080 |
Why?
| | Enterocolitis | 1 | 2008 | 32 | 0.080 |
Why?
| | Sequence Analysis, RNA | 1 | 2010 | 409 | 0.080 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 180 | 0.080 |
Why?
| | Cytokines | 3 | 2021 | 1900 | 0.080 |
Why?
| | Biomarkers | 3 | 2017 | 3588 | 0.080 |
Why?
| | Adaptation, Biological | 1 | 2007 | 57 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 190 | 0.070 |
Why?
| | Demography | 1 | 2007 | 274 | 0.070 |
Why?
| | Viruses | 1 | 2007 | 96 | 0.070 |
Why?
| | Mammals | 1 | 2008 | 253 | 0.070 |
Why?
| | Models, Biological | 2 | 2013 | 1715 | 0.070 |
Why?
| | Twins, Monozygotic | 3 | 2012 | 214 | 0.070 |
Why?
| | Oligoribonucleotides | 1 | 2005 | 52 | 0.070 |
Why?
| | Adaptation, Physiological | 4 | 2011 | 502 | 0.070 |
Why?
| | Polymorphism, Genetic | 2 | 2010 | 642 | 0.060 |
Why?
| | DNA Primers | 2 | 2007 | 533 | 0.060 |
Why?
| | Neurotransmitter Agents | 2 | 2017 | 76 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2018 | 180 | 0.060 |
Why?
| | Species Specificity | 3 | 2011 | 565 | 0.060 |
Why?
| | DNA Polymerase I | 1 | 2003 | 26 | 0.060 |
Why?
| | Age Factors | 3 | 2018 | 2995 | 0.060 |
Why?
| | Aging | 1 | 2013 | 1670 | 0.060 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 32 | 0.060 |
Why?
| | Recombination, Genetic | 1 | 2003 | 173 | 0.060 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 28 | 0.060 |
Why?
| | Mental Disorders | 1 | 2011 | 939 | 0.050 |
Why?
| | Interleukin-12 | 1 | 2022 | 110 | 0.050 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 143 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 175 | 0.050 |
Why?
| | Mothers | 2 | 2018 | 682 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 129 | 0.050 |
Why?
| | Protein Binding | 2 | 2005 | 1975 | 0.050 |
Why?
| | Codon, Terminator | 1 | 2001 | 21 | 0.050 |
Why?
| | Aged | 5 | 2019 | 19657 | 0.050 |
Why?
| | Systems Biology | 1 | 2021 | 57 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2022 | 225 | 0.050 |
Why?
| | Blastocystis hominis | 1 | 2020 | 1 | 0.050 |
Why?
| | Entamoeba | 1 | 2020 | 2 | 0.050 |
Why?
| | Twins, Dizygotic | 2 | 2012 | 182 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2012 | 1794 | 0.050 |
Why?
| | Cryptosporidium | 1 | 2020 | 12 | 0.050 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 22 | 0.050 |
Why?
| | Candida | 1 | 2020 | 35 | 0.050 |
Why?
| | Methionine-tRNA Ligase | 1 | 2019 | 1 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 372 | 0.050 |
Why?
| | Giardia lamblia | 1 | 2020 | 17 | 0.050 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 37 | 0.050 |
Why?
| | Clostridium Infections | 1 | 2019 | 57 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2020 | 100 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 35 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 201 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 302 | 0.040 |
Why?
| | Nucleotides | 2 | 2010 | 112 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 983 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 120 | 0.040 |
Why?
| | 2-Propanol | 1 | 2017 | 21 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 736 | 0.040 |
Why?
| | Databases, Genetic | 2 | 2011 | 253 | 0.040 |
Why?
| | Administration, Oral | 1 | 2019 | 756 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2018 | 167 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1094 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2018 | 247 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2013 | 4908 | 0.040 |
Why?
| | Epigenomics | 1 | 2017 | 107 | 0.040 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2017 | 81 | 0.040 |
Why?
| | HIV Protease Inhibitors | 1 | 2017 | 64 | 0.040 |
Why?
| | Gene Library | 1 | 2017 | 127 | 0.040 |
Why?
| | Prospective Studies | 2 | 2018 | 6471 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2001 | 2071 | 0.040 |
Why?
| | Electrocardiography | 1 | 2019 | 556 | 0.040 |
Why?
| | Biopsy | 1 | 2020 | 1079 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 827 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 148 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1687 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1945 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 336 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2019 | 290 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 502 | 0.030 |
Why?
| | Air Pollution | 1 | 2017 | 209 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1231 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1067 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2013 | 46 | 0.030 |
Why?
| | Allergens | 1 | 2017 | 424 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2326 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3171 | 0.030 |
Why?
| | Ear, Middle | 1 | 2013 | 92 | 0.030 |
Why?
| | Overweight | 1 | 2017 | 502 | 0.030 |
Why?
| | Mutation | 1 | 2003 | 3457 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1171 | 0.030 |
Why?
| | Venezuela | 1 | 2012 | 7 | 0.030 |
Why?
| | Cilia | 1 | 2013 | 160 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 31 | 0.030 |
Why?
| | Malawi | 1 | 2012 | 50 | 0.030 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 28 | 0.030 |
Why?
| | San Francisco | 1 | 2012 | 57 | 0.030 |
Why?
| | Dogs | 1 | 2013 | 371 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 540 | 0.030 |
Why?
| | Lactobacillus | 1 | 2011 | 23 | 0.030 |
Why?
| | Models, Statistical | 1 | 2016 | 636 | 0.030 |
Why?
| | Phagocytosis | 1 | 2013 | 364 | 0.030 |
Why?
| | Family Characteristics | 1 | 2013 | 156 | 0.030 |
Why?
| | United States | 2 | 2022 | 12555 | 0.030 |
Why?
| | Chronic Disease | 2 | 2008 | 1636 | 0.030 |
Why?
| | Programming Languages | 1 | 2011 | 24 | 0.030 |
Why?
| | Probiotics | 1 | 2011 | 49 | 0.020 |
Why?
| | Formates | 1 | 2011 | 13 | 0.020 |
Why?
| | Checklist | 1 | 2011 | 81 | 0.020 |
Why?
| | Base Pairing | 1 | 2010 | 59 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2011 | 140 | 0.020 |
Why?
| | South America | 1 | 2010 | 56 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1267 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2011 | 124 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2018 | 1774 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2010 | 69 | 0.020 |
Why?
| | Ecological and Environmental Phenomena | 1 | 2009 | 6 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 394 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 508 | 0.020 |
Why?
| | Citrus | 1 | 2009 | 4 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2010 | 219 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 4552 | 0.020 |
Why?
| | DNA | 2 | 2007 | 1388 | 0.020 |
Why?
| | RNA, Transfer | 1 | 2010 | 119 | 0.020 |
Why?
| | North America | 1 | 2010 | 266 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 355 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2010 | 536 | 0.020 |
Why?
| | Carnivora | 1 | 2008 | 7 | 0.020 |
Why?
| | Animals, Zoo | 1 | 2008 | 12 | 0.020 |
Why?
| | Insulin | 1 | 2018 | 2162 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2025 | 0.020 |
Why?
| | Animals, Wild | 1 | 2008 | 47 | 0.020 |
Why?
| | Hand | 1 | 2009 | 137 | 0.020 |
Why?
| | Lentiviruses, Primate | 1 | 2008 | 13 | 0.020 |
Why?
| | Conjugation, Genetic | 1 | 2007 | 5 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 32 | 0.020 |
Why?
| | Gene Products, gag | 1 | 2007 | 38 | 0.020 |
Why?
| | Primates | 1 | 2008 | 114 | 0.020 |
Why?
| | Gene Duplication | 1 | 2007 | 64 | 0.020 |
Why?
| | Proteobacteria | 1 | 2007 | 17 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1012 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1435 | 0.020 |
Why?
| | von Willebrand Factor | 1 | 2007 | 58 | 0.020 |
Why?
| | BRCA1 Protein | 1 | 2007 | 57 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 102 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3174 | 0.020 |
Why?
| | Macrophages | 1 | 2013 | 1324 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 1868 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2007 | 278 | 0.020 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2007 | 170 | 0.020 |
Why?
| | Bacteriophages | 1 | 2007 | 76 | 0.020 |
Why?
| | Computer Simulation | 1 | 2010 | 922 | 0.020 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 144 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 2005 | 85 | 0.020 |
Why?
| | Mice, Obese | 1 | 2005 | 58 | 0.020 |
Why?
| | Ligands | 1 | 2007 | 567 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2007 | 396 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1137 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2007 | 455 | 0.020 |
Why?
| | Cyanobacteria | 1 | 2005 | 62 | 0.020 |
Why?
| | DNA, Protozoan | 1 | 2003 | 28 | 0.020 |
Why?
| | Up-Regulation | 1 | 2007 | 872 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2007 | 736 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 155 | 0.010 |
Why?
| | Protein Conformation | 1 | 2007 | 848 | 0.010 |
Why?
| | Mosaicism | 1 | 2003 | 62 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2062 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2010 | 2874 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 702 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1224 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 473 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6561 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2275 | 0.010 |
Why?
| | Signal Transduction | 1 | 2007 | 4709 | 0.010 |
Why?
|
|
Lozupone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|